Prognostic Significance of the Location of Lymph Node Metastases in Patients With Adenocarcinoma of the Distal Esophagus or Gastroesophageal Junction

被引:34
作者
Anderegg, Maarten C. J. [1 ]
Lagarde, Sjoerd M. [1 ,2 ]
Jagadesham, Vamshi P. [2 ]
Gisbertz, Suzanne S. [1 ]
Immanuel, Arul [2 ]
Meijer, Sybren L. [3 ]
Hulshof, Maarten C. C. M. [4 ]
Bergman, Jacques J. G. H. M. [5 ]
van Laarhoven, Hanneke W. M. [6 ]
Griffin, S. Michael [2 ]
Henegouwen, Mark I. van Berge [1 ]
机构
[1] Acad Med Ctr, Dept Surg, G4-138,Meibergdreef 9, NL-1100 DD Amsterdam, Netherlands
[2] Royal Victoria Infirm, Northern Oesophagogastr Canc Unit, Newcastle Upon Tyne, Tyne & Wear, England
[3] Acad Med Ctr, Dept Pathol, Amsterdam, Netherlands
[4] Acad Med Ctr, Dept Radiat Oncol, Amsterdam, Netherlands
[5] Acad Med Ctr, Dept Gastroenterol, Amsterdam, Netherlands
[6] Acad Med Ctr, Dept Med Oncol, Amsterdam, Netherlands
关键词
(neo)adjuvant treatment; esophageal; GEJ adenocarcinoma; location of lymph node metastases; transthoracic esophagectomy; ESOPHAGOGASTRIC JUNCTION; PREDICTS SURVIVAL; NEOADJUVANT CHEMORADIOTHERAPY; 7TH EDITION; CANCER; CARCINOMA; CLASSIFICATION; ESOPHAGECTOMY; CHEMOTHERAPY; METAANALYSIS;
D O I
10.1097/SLA.0000000000001767
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective:To identify the prognostic significance of the location of lymph node metastases in patients with esophageal or gastroesophageal junction (GEJ) adenocarcinoma treated with neoadjuvant therapy followed by esophagectomy.Background:Detection of lymph node metastases in the upper mediastinum and around the celiac trunk after neoadjuvant therapy and resection does not alter the TNM classification of esophageal carcinoma. The impact of these distant lymph node metastases on survival remains unclear.Methods:Between March 2003 and September 2013, 479 consecutive patients with adenocarcinoma of the distal esophagus or GEJ who underwent transthoracic esophagectomy with en bloc 2-field lymphadenectomy after neoadjuvant therapy were included, and survival was analyzed according to the location of positive lymph nodes in the resection specimen.Results:Two hundred fifty-three patients had nodal metastases in the resection specimen. Of these patients, 92 patients had metastases in locoregional nodes, 114 patients in truncal nodes, 21 patients in the proximal field of the chest, and 26 patients had both positive truncal and proximal field nodes. Median disease-free survival was 170 months in the absence of nodal metastases, 35 months for metastases limited to locoregional nodes, 16 months for positive truncal nodes, 15 months for positive nodes in the proximal field, and 8 months for nodal metastases in both truncal and the proximal field. On multivariate analysis, location of lymph node metastases was independently associated with survival.Conclusions:Location of lymph node metastases is an independent predictor for survival. Relatively distant lymph node metastases along the celiac axis and/or the proximal field have a negative impact on survival. Location of lymph node metastases should therefore be considered in future staging systems of esophageal and GEJ adenocarcinoma.
引用
收藏
页码:847 / 853
页数:7
相关论文
共 33 条
[1]   Total number of resected lymph nodes predicts survival in esophageal cancer [J].
Altorki, Nasser K. ;
Zhou, Xi Kathy ;
Stiles, Brendon ;
Port, Jeffrey L. ;
Paul, Subroto ;
Lee, Paul C. ;
Mazumdar, Madhu .
ANNALS OF SURGERY, 2008, 248 (02) :221-226
[2]  
[Anonymous], 2014 ASCO ANN M
[3]   Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial [J].
Biere, Surya S. A. Y. ;
Henegouwen, Mark I. van Berge ;
Maas, Kirsten W. ;
Bonavina, Luigi ;
Rosman, Camiel ;
Roig Garcia, Josep ;
Gisbertz, Suzanne S. ;
Klinkenbijl, Jean H. G. ;
Hollmann, Markus W. ;
de lange, Elly S. M. ;
Bonjer, H. Jaap ;
van der Peet, Donald L. ;
Cuesta, Miguel A. .
LANCET, 2012, 379 (9829) :1887-1892
[4]   Chemotherapy Followed by Surgery in Patients With Carcinoma of the Distal Esophagus and Celiac Lymph Node Involvement [J].
Boonstra, J. J. ;
Koppert, L. B. ;
Wijnhoven, B. P. ;
Tilanus, H. W. ;
Van Dekken, H. ;
Tran, T. C. K. ;
Van der Gaast, A. .
JOURNAL OF SURGICAL ONCOLOGY, 2009, 100 (05) :407-413
[5]   Epidemiology and Risk Factors for Gastroesophageal Junction Tumors: Understanding the Rising Incidence of This Disease [J].
Buas, Matthew F. ;
Vaughan, Thomas L. .
SEMINARS IN RADIATION ONCOLOGY, 2013, 23 (01) :3-9
[6]   Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial [J].
Burmeister, BH ;
Smithers, BM ;
Gebski, V ;
Fitzgerald, L ;
Simes, RJ ;
Devitt, P ;
Ackland, S ;
Gotley, DC ;
Joseph, D ;
Millar, J ;
North, J ;
Walpole, ET ;
Denham, JW .
LANCET ONCOLOGY, 2005, 6 (09) :659-668
[7]   Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial [J].
Burmeister, Bryan H. ;
Thomas, Janine M. ;
Burmeister, Elizabeth A. ;
Walpole, Euan T. ;
Harvey, Jennifer A. ;
Thomson, Damien B. ;
Barbour, Andrew P. ;
Gotley, David C. ;
Smithers, B. Mark .
EUROPEAN JOURNAL OF CANCER, 2011, 47 (03) :354-360
[8]   Nodal Metastasis From Locally Advanced Esophageal Cancer: How Neoadjuvant Therapy Modifies Their Frequency and Distribution [J].
Castoro, Carlo ;
Scarpa, Marco ;
Cagol, Matteo ;
Ruol, Alberto ;
Cavallin, Francesco ;
Alfieri, Rita ;
Zanchettin, Gianpietro ;
Rugge, Massimo ;
Ancona, Ermanno .
ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (13) :3743-3754
[9]   Ex vivo dissection increases lymph node yield in oesophagogastric cancer [J].
Cichowitz, Adam ;
Burton, Paul ;
Brown, Wendy ;
Smith, Andrew ;
Shaw, Kalai ;
Slamowicz, Ron ;
Nottle, Peter D. .
ANZ JOURNAL OF SURGERY, 2015, 85 (1-2) :80-84
[10]   Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis [J].
Gebski, Val ;
Burmeister, Bryan ;
Smithers, B. Mark ;
Foo, Kerwyn ;
Zalcberg, John ;
Simes, John .
LANCET ONCOLOGY, 2007, 8 (03) :226-234